Endostar

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Endostar
Accession Number
DB11727
Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Description

Endostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
  • Endostatin, N-terminal-MGGSHHHHH
Categories
Not Available
UNII
GVG18ZDN65
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911232

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
1RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
1Unknown StatusTreatmentNeoplasms, Colorectal1
2Active Not RecruitingTreatmentNasopharyngeal Neoplasms1
2CompletedTreatmentAdvanced Gastric Cancer1
2CompletedTreatmentAdvanced Non-Small Cell Lung Cancer1
2CompletedTreatmentHepatocellular,Carcinoma / Portal Vein Tumor Thrombus1
2CompletedTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
2CompletedTreatmentLung Cancer Small Cell Lung Cancer (SCLC)1
2CompletedTreatmentMalignant Ascites / Malignant Pleural Effusions1
2Not Yet RecruitingTreatmentEsophageal Cancers1
2Not Yet RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
2Not Yet RecruitingTreatmentNasopharyngeal Carcinoma2
2RecruitingTreatmentCancer, Breast1
2RecruitingTreatmentEndostatin / Radiation Pneumonitis1
2RecruitingTreatmentEsophageal1
2RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
2RecruitingTreatmentLung Cancers2
2RecruitingTreatmentMelanoma1
2RecruitingTreatmentNasopharyngeal Carcinoma2
2RecruitingTreatmentNeuroblastomas1
2RecruitingTreatmentPeripheral T-Cell Lymphoma (PTCL)1
2RecruitingTreatmentSoft Tissue Sarcoma, Adult, Stage IIB1
2RecruitingTreatmentSquamous Cell Carcinoma of Esophagus3
2RecruitingTreatmentUterine Cervical Neoplasms1
2Unknown StatusDiagnosticAdvanced Primary Lung Adenocarcinoma1
2Unknown StatusTreatmentAdvanced Colorectal Cancer1
2Unknown StatusTreatmentColorectal Cancers1
2Unknown StatusTreatmentEsophageal Cancers1
2Unknown StatusTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)3
2Unknown StatusTreatmentMetastatic Brain Tumors1
2Unknown StatusTreatmentMetastatic Colorectal Cancers1
2Unknown StatusTreatmentNasopharyngeal Carcinoma1
2Unknown StatusTreatmentNeoplasms, Colorectal1
2Unknown StatusTreatmentSarcoma, Osteogenic1
2Unknown StatusTreatmentSoft Tissue Sarcoma (STS)1
2Unknown StatusTreatmentT Cell Lymphomas2
2, 3Unknown StatusTreatmentLung Cancers1
3Active Not RecruitingPreventionLung Cancer Non-Small Cell Cancer (NSCLC)1
3CompletedTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
3Enrolling by InvitationTreatmentNasopharyngeal Neoplasms1
3Not Yet RecruitingTreatmentAngiogenesis / Cancer, Breast1
3Not Yet RecruitingTreatmentCervical Carcinoma1
3Not Yet RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC) / Malignant Hydrothorax1
3Not Yet RecruitingTreatmentNasopharyngeal Carcinoma1
3Unknown StatusScreeningNeoplasms, Lung1
3Unknown StatusTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
3Unknown StatusTreatmentMalignant Neoplasm of Stomach1
4CompletedTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
4RecruitingTreatmentAdenocarcinoma of the Lung1
4RecruitingTreatmentAdvanced Lung Squamous Carcinoma1
4RecruitingTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1
4Unknown StatusTreatmentLung Cancer Non-Small Cell Cancer (NSCLC)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on October 20, 2016 14:42 / Updated on June 04, 2019 07:26